InsiderTrades

Form 4 for CRMD CorMedix Inc.

Accepted 2025-12-19 00:00:00 ET · period of report 2025-12-18 · accession 0001213900-25-124063 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-12-19 2025-12-18 CRMD Todisco Joseph CEO, Dir M - OptEx $4.43 +30.0K 539.5K +6% +$132.9K
D 2025-12-19 2025-12-18 CRMD Todisco Joseph CEO, Dir S - Sale+OE $12.00 -30.0K 509.5K -6% -$360.0K
D 2025-12-19 2025-12-18 CRMD Todisco Joseph CEO, Dir M - OptEx $0.00 -30.0K 370.0K -8% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-12-18 M A 30,000 $4.43 539,496 D — —
2 Common Common Stock 2025-12-18 S D 30,000 $12.00 509,496 D — — (F1) This transaction was executed in multiple trades at prices ranging from $12.00 to $12.02, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
3 Derivative Stock Option (Right to Buy Common Stock) 2025-12-18 M D 30,000 $0.00 370,000 D $4.43 · — to 2033-01-14 30,000 Common Stock (F2) These options were granted on 01/14/2023. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.